2005
DOI: 10.4269/ajtmh.2005.72.458
|View full text |Cite
|
Sign up to set email alerts
|

Induction of Protective Immunity Against Scrub Typhus With a 56-Kilodalton Recombinant Antigen Fused With a 47-Kilodalton Antigen of Orientia Tsutsugamushi Karp

Abstract: A partial gene sequence encoding the 56-kD scrub typhus antigen (Sta56) was amplified from genomic DNA of the Orientia tsutsugamushi Karp strain by a polymerase chain reaction (PCR). The PCR product was ligated with the 47-kD scrub typhus antigen (Sta47) gene in the pQE30/47 expression vector, and the resulting recombinant expression vector was designated pQE30/56-47. A fusion antigen (Sta56-47) was expressed in Escherichia coli cells transformed with pQE30/56-47 after induction with isopropyl-beta-d-thiogalac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
50
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(52 citation statements)
references
References 34 publications
0
50
0
Order By: Relevance
“…MLD50. Thus, Balb/c mice were infected with diluted doses of an immunofocus assay-quantified inoculum in order to determine the MLD50 by probit analysis as reported previously [29] (Fig. 1D, right panel).…”
Section: Resultsmentioning
confidence: 99%
“…MLD50. Thus, Balb/c mice were infected with diluted doses of an immunofocus assay-quantified inoculum in order to determine the MLD50 by probit analysis as reported previously [29] (Fig. 1D, right panel).…”
Section: Resultsmentioning
confidence: 99%
“…This protein is a member of the HtrA protein family, which is characterized by serine protease and chaperone activities. The 47-kD HtrA gene and gene product of the Karp strain have been used to develop DNA (Niu et al 2003, Xu et al 2005) and recombinant protein (Niu et al 2003, Yu et al 2005) vaccine candidates displaying immunogenicity and efficacy in mouse scrub typhus models. Recent evaluations in our laboratory have shown not only that the pKarp47 DNA vaccine candidate is highly effective in protecting CD-1 outbred mice from homologous challenge, but also in protecting them from heterologous challenge from 4 of 17 disparate isolates using a single immunization (A.L.R., unpublished data).…”
Section: Introductionmentioning
confidence: 99%
“…These developments are presently driving renewed efforts to develop a vaccine, particularly by the US Department of Defense. Modern technologies such as DNA vaccines [67][68][69], recombinant proteins [70][71][72], and combination DNA-protein vaccines appear to be promising strategies for disease prevention, as was recently suggested elsewhere [38].…”
mentioning
confidence: 99%